Philips Japan Launches SmartIQ Technology for Enhanced Cardiac Catheter Imaging
In a significant advancement for cardiovascular healthcare, Philips Japan has officially launched SmartIQ Technology, a state-of-the-art imaging solution designed to enhance the quality of images obtained during cardiac catheter treatments while minimizing patient exposure to radiation and the volume of contrast agents used. This innovative technology will be integrated into the Azurion vascular imaging system, marking a pivotal development in the field of minimally invasive procedures.
Japan is experiencing a rise in cardiovascular diseases coinciding with an aging population. With this surge in conditions necessitating interventional procedures comes a heightened demand for solutions that can efficiently manage both the patient's burden and the workflow of healthcare professionals. As the need for low-invasive catheter treatments grows, achieving a delicate balance between high-quality imaging and reduced exposure risks has become critical.
The newly launched SmartIQ Technology is a product of collaborative research with leading cardiovascular centers, and it employs real-time imaging algorithms to sustain high-quality visuals even in complex scenarios. Here are some key features:
1. Content-Aware Imaging Algorithm: This advanced feature integrates the principles of X-ray physics with clinical data to intelligently separate clinically relevant image information from background noise. This ensures that essential details are visible without compromising the clarity of the image.
2. Ultralow Dose Protocol: By focusing on reducing isolated noise, this protocol allows for high-quality images to be captured using radiation levels comparable to those in fluoroscopy. This is crucial for both patient safety and diagnostic accuracy.
3. Low Contrast Protocol: SmartIQ Technology enhances selective contrast for critical components, thereby aiding the preservation of image quality even when using lower-concentration contrast agents.
4. SafeGuard Design: This feature continuously compares processed images with original visuals, ensuring the integrity of clinical information remains intact throughout the diagnosis and treatment process.
5. Customizable Protocol Design: Users can easily select optimal protocols based on the specific needs of routine checks or complex coronary interventions, enhancing operational flexibility for healthcare providers. Importantly, existing Azurion systems can also adopt this technology.
To bring this technology to the forefront of healthcare solutions, Philips plans to showcase SmartIQ Technology at prominent medical conferences, including CVIT 2026, which focuses on cardiovascular intervention. This exposure aims to educate a broader audience of medical practitioners about the advantages of SmartIQ.
Founded in 1953, Philips Japan is the Japanese entity of Royal Philips, a global leader in healthcare technology. The company focuses on delivering innovative medical devices and providing health solutions to improve the quality of life for people, especially in light of Japan's rapidly aging demographic. With approximately 2,000 employees and operations across 70 locations, Philips Japan is committed to advancing healthcare technology for better health outcomes.
Royal Philips, headquartered in the Netherlands, strives to improve people's health and well-being through innovative technologies and solutions. The company's extensive work in imaging diagnostics, ultrasound, and health informatics makes it a key player in the healthcare sector globally, boasting around 64,800 employees and a presence in over 100 countries. For further updates and corporate information, please visit Philips News Center.
Background to the Launch
Japan is experiencing a rise in cardiovascular diseases coinciding with an aging population. With this surge in conditions necessitating interventional procedures comes a heightened demand for solutions that can efficiently manage both the patient's burden and the workflow of healthcare professionals. As the need for low-invasive catheter treatments grows, achieving a delicate balance between high-quality imaging and reduced exposure risks has become critical.
Features of SmartIQ Technology
The newly launched SmartIQ Technology is a product of collaborative research with leading cardiovascular centers, and it employs real-time imaging algorithms to sustain high-quality visuals even in complex scenarios. Here are some key features:
1. Content-Aware Imaging Algorithm: This advanced feature integrates the principles of X-ray physics with clinical data to intelligently separate clinically relevant image information from background noise. This ensures that essential details are visible without compromising the clarity of the image.
2. Ultralow Dose Protocol: By focusing on reducing isolated noise, this protocol allows for high-quality images to be captured using radiation levels comparable to those in fluoroscopy. This is crucial for both patient safety and diagnostic accuracy.
3. Low Contrast Protocol: SmartIQ Technology enhances selective contrast for critical components, thereby aiding the preservation of image quality even when using lower-concentration contrast agents.
4. SafeGuard Design: This feature continuously compares processed images with original visuals, ensuring the integrity of clinical information remains intact throughout the diagnosis and treatment process.
5. Customizable Protocol Design: Users can easily select optimal protocols based on the specific needs of routine checks or complex coronary interventions, enhancing operational flexibility for healthcare providers. Importantly, existing Azurion systems can also adopt this technology.
Future Plans for Demonstrations
To bring this technology to the forefront of healthcare solutions, Philips plans to showcase SmartIQ Technology at prominent medical conferences, including CVIT 2026, which focuses on cardiovascular intervention. This exposure aims to educate a broader audience of medical practitioners about the advantages of SmartIQ.
Additional Information on Philips Japan
Founded in 1953, Philips Japan is the Japanese entity of Royal Philips, a global leader in healthcare technology. The company focuses on delivering innovative medical devices and providing health solutions to improve the quality of life for people, especially in light of Japan's rapidly aging demographic. With approximately 2,000 employees and operations across 70 locations, Philips Japan is committed to advancing healthcare technology for better health outcomes.
About Royal Philips
Royal Philips, headquartered in the Netherlands, strives to improve people's health and well-being through innovative technologies and solutions. The company's extensive work in imaging diagnostics, ultrasound, and health informatics makes it a key player in the healthcare sector globally, boasting around 64,800 employees and a presence in over 100 countries. For further updates and corporate information, please visit Philips News Center.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.